[e-mail]

CombiMatrix: Full Array of Pending Catalysts

Mike, at least get your cut and paste facts straight. The litigation is $36M not $50M. Plus you need to factor in that upon payment CBMX will owe out attorneys fees and $10M to a creditor that loaned them money backed by the litigation. That reduces your windfall estimate to less than half what you mistakenly thought.

The lab revenues indeed went up 53% but we're talking just $395,000 in sales, big deal.

Do the company's you publish articles on or do interviews with compensate you in any way?

Why Would an Insider Be Selling Protalix Shares Now of All Times?

Perhaps he's selling because he thinks PLX shares are fully valued. A knockoff of Cerezyme with a more powerful Shire competing as well probably isn't worth a substantial amount of sales.

Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval

I don't think Saito will want to think about vion for a long time. I also don't think someone needs to be a scientist to analyze a biotech. However in vion's case the entire bear case was spelled out in their clinical data and reiterated with the briefing documents. How vion bulls can ignore all that and continue to hold, if not buy more on the way down and a phony pundit like Garza thinks it's a buying opportunity shows just how ignorant most investors are.

Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval

Saito, did you watch the panel meeting? I take it no. It has nothing to do with the fda going against their guidance. One panelist asked why any doctor would want to give this to his patients. C.

Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval

Unanimous vote against approval. Awful call Saito and even reiterated after seeing the disastrous briefing documents. Hard to imagine you're a biomechanical engineer, i figured someone with your background would be more diligent and evidence oriented. Maybe you should stick to what you know, devices. Garza, another nice call on the "buying opportunity" for biomedreports. Charles.

Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval

Saito, i'm sorry, you seem sincere, but you are completely clueless. These were the ugliest briefing documents i've ever seen. Briefing docs are not always ugly. The vion filing is more or less a joke. I don't understand how you can so easily brush aside their concerns. Do you realize the downside if the fda says no is bankruptcy? I will be stunned if the fda panel recommends approval. I tried very hard to find shares to short at $6+ but couldn't find any. Oh well. Garza, i hope you bought.

Interview with Access Pharma CEO: Updates and Outlook

The ceo is focused on the media because he knows this is a retail driven market and knows any smart institution knows its bogus. He'll keep trying to pump the stock through people like Havrilla and all these scam website blogs and pull off a fund raise if he can.

Does Immunomedics' Success Mean Human Genome Sciences' Failure?

Idaho, thanks for the link. I'll take a look.

Charles


NO Hypermetabolic activity on the PET scan,
> his CT scan just an ill defined mass, which was likened to a scar
> from a burn. He feels great, gained weight, HAS HOPE, and while we
> know he's not out of the woods.., are encouraged and looking forward
> to the next meeting in mid-August and moving on from there.
>
> There are a lot of people who may read this, some curious and others
> who've found their way here because they or someone else they know
> and love are ill and looking for help wherever they can find it.
> That's what happened to our family, and when I got here found something
> that at the absolute least is a compassionate way to treat an illness,
> but most importantly is an effective way to fight back against it.
>


>

Does Immunomedics' Success Mean Human Genome Sciences' Failure?

Idaho, if you could post a link to where to find the pancreatic trial comments that would be appreciated.

I still think Garza's comments about the immu lupus data vs hgsi are incredibly misinformed.

Interview with Access Pharma CEO: Updates and Outlook

I liked this line: "Not that ProLindac wouldn't be successful there"

I guess no reason to do trials any more, lets just take Davis and Havrilla's word for it th at a higher bioavailability of a toxic chemo will give better efficacy with no increase in side effects not to mention eloxatin is going generic. What i do want to know is just how many pump articles can you write on one stock? Mugard is a total dud by the way, ice chips work just as well.

Does Immunomedics' Success Mean Human Genome Sciences' Failure?

Actually it was smart to short IMMU at 7.50 on bogus news that fake commentators like Garza touted and here it is a few days later in the 5's. I don't care about immu long term or the cancer program, the stock is overvalued and ran an absurd amount on non news. I was just following the smart money that would have blown out on a release like that.

As far as "humanized" rituxan, great idea, why don't you take a look at Genmab and the trouble they've been having not to mention Genentech has their own humab Rituxan.

Does Immunomedics' Success Mean Human Genome Sciences' Failure?

Long immu isn't too smart, you sell when a stock jumps 75% after releasing skimpy data that doesn't say anything. I went short. When you see so little data, it's what the PR doesn't say not what little it did say. What were the side effects? Was there a dose response? What was the p-value? I think when the data is fully revealed it won't look so good otherwise they would have been happy to disclose it all without bias.

Regarding Garza, his articles are so bad, cut and paste when he's at his best and downhill from there once he starts giving opinions, why does anyone actually pay to subscribe to his website?

Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval

The fda briefing documents are ugly.

Vion Pharmaceuticals' Onrigin: Good Chance of FDA Approval

VION has ZERO chance for approval. I seriously doubt a panel will recommend this garbage compound. I hope you have good risk management and haven't put all your eggs into this one.

CEL-SCI CEO's Bullish Biotech Play

CelSci is a huge scam. Can't you write an article on a legitimate company that doesn't need pump and dump help? At least throw people off with something real once in a while.